ANIK Q1 2021 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$34M-3.1% YoY

Gross Profit

$21M61.2% margin

Operating Income

$1M3.7% margin

Net Income

$3M8.3% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$362M

Total Liabilities

$86M

Stockholders' Equity

$277M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$35M	-3.1%
Gross Profit	$21M	$21M	-1.1%
Operating Income	$1M	$7M	-82.3%
Net Income	$3M	$6M	-51.0%

Revenue Segments

Product

$34M50%

Joint Pain Management Therapies

$19M28%

Joint Preservation and Restoration

$12M18%

Manufactured Product, Other

$3M4%

Geographic Segments

UNITED STATES

$25M82%

Europe

$5M18%